Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner
10.1186/1475-2840-12-154
Saved in:
Main Authors: | Hausenloy D.J., Whittington H.J., Wynne A.M., Begum S.S., Theodorou L., Riksen N., Mocanu M.M., Yellon D.M. |
---|---|
其他作者: | DUKE-NUS MEDICAL SCHOOL |
格式: | Article |
出版: |
BioMed Central
2018
|
在線閱讀: | http://scholarbank.nus.edu.sg/handle/10635/143923 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
相似書籍
-
Effects of dipeptidyl peptidase-4 inhibitor in insulin-resistant rats with myocardial infarction
由: Nattayaporn Apaijai, et al.
出版: (2018) -
Effects of dipeptidyl peptidase-4 inhibitor in insulin-resistant rats with myocardial infarction
由: Apaijai N., et al.
出版: (2017) -
Reducing myocardial infarct size: Challenges and future opportunities
由: Bulluck, H, et al.
出版: (2020) -
Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction
由: Inthachai T., et al.
出版: (2015) -
Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction
由: Tharnwimol Inthachai, et al.
出版: (2018)